Aptevo Therapeutics

APVO • NASDAQ • Stock Fundamentals

Aptevo Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jeffrey G. Lamothe, with a market cap of $6.1M.

Market Cap$6.1M

Employees40.0

CEOJeffrey G. Lamothe

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026

Next EarningsAug 10, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Aptevo Therapeutics

Aptevo Therapeutics (APVO) has a market capitalization of $6.1M and trades on NASDAQ.

Aptevo Therapeutics has approximately 40 employees.